Diagnostic and neuropathogenesis issues in human African trypanosomiasis

PGE Kennedy - International journal for parasitology, 2006 - Elsevier
Human African trypanosomiasis, also known as sleeping sickness, is caused by protozoan
parasites of the genus Trypanosoma, and is a major cause of human mortality and morbidity …

Human African trypanosomiasis: epidemiology and control

EM Fèvre, K Picozzi, J Jannin, SC Welburn… - Advances in …, 2006 - Elsevier
Human African trypanosomiasis (HAT), or sleeping sickness, describes not one but two
discrete diseases: that caused by Trypanosoma brucei rhodesiense and that caused by T. b …

Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor

TN Baral, S Magez, B Stijlemans, K Conrath… - Nature medicine, 2006 - nature.com
High systemic drug toxicity and increasing prevalence of drug resistance hampers efficient
treatment of human African trypanosomiasis (HAT). Hence, development of new highly …

Discovery of Trypanocidal Compounds by Whole Cell HTS of Trypanosoma brucei

ZB Mackey, AM Baca, JP Mallari… - Chemical biology & …, 2006 - Wiley Online Library
Chemotherapy against human African trypanosomiasis relies on four drugs that cause
frequent and occasionally severe side‐effects. Because human African trypanosomiasis is a …

Human African trypanosomiasis–neurological aspects

PGE Kennedy - Journal of neurology, 2006 - Springer
Abstract Human African Trypanosomiasis (HAT), which is also known as sleeping sickness,
is a major cause of death and disability in 36 countries in sub-Saharan Africa. The disease is …

Targeting of toxic compounds to the trypanosome's interior

MP Barrett, IH Gilbert - Advances in parasitology, 2006 - Elsevier
Drugs can be targeted into African trypanosomes by exploiting carrier proteins at the surface
of these parasites. This has been clearly demonstrated in the case of the melamine-based …

A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats

BM Anene, RC Ezeokonkwo, TI Mmesirionye… - Parasitology, 2006 - cambridge.org
Trypanosomosis is a major cause of mortality for dogs in Nigeria and treatment with
diminazene aceturate has steadily become less effective, either as a result of low quality of …

Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance

CA Lanteri, ML Stewart, JM Brock, VP Alibu… - Molecular …, 2006 - ASPET
A novel trypanocide, 2, 5-bis (4-amidinophenyl) furan (DB75), in its prodrug amidoxime-
derivative form, 2, 5-bis (4-amidinophenyl) furan-bis-O-methylamidoxime (DB289), is in trials …

Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategies

WO Inojosa, I Augusto, Z Bisoffi, T Josenado, PM Abel… - Bmj, 2006 - bmj.com
Objective To assess the operational feasibility of detecting human African trypanosomiasis
by active and passive case finding using the card agglutination test with serial dilution of …

[PDF][PDF] Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo

M Balasegaram, S Harris, F Checchi… - Bulletin of the World …, 2006 - SciELO Public Health
OBJECTIVE: In 2002-03, the Republic of the Congo increased the threshold separating
stage 1 and 2 cases of human African trypanosomiasis (HAT) from a cerebrospinal fluid …